CompaniesGeneriQ Pharma

GeneriQ Pharma

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (7)
View all

Total Trials

7

As Lead Sponsor

7

As Collaborator

0

Total Enrollment

1,308

By Phase

PHASE2/PHASE3: 1

By Status

COMPLETED: 5UNKNOWN: 2
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
NCT01327729
NCT02618122
NCT02626013
NCT03353545
NCT03780504
Hover over trial bars to see details

Recent Trials

NCT03780504Lead Sponsor
Apremilast in Psoriatic Arthritis in Real-life Clinical Practice in Greece
N/AUnknown
170 participants
Started: Apr 15, 2019 · Completed: Dec 31, 2022
NCT03353545Lead Sponsor
Retrospective and Prospective Study of POmalidomide Plus LoW Dose Dexa Efficacy in RRMM Patients Under Real-Life Conditions
N/ACompleted
110 participants
Started: Nov 16, 2017 · Completed: Feb 28, 2020
NCT03059953Lead Sponsor
A Study of Treatment With APRemilast in Moderate psoriAsIS in Real Life clinicAL Practice (The 'APRAISAL' Study)
N/ACompleted
302 participants
Started: Apr 7, 2017 · Completed: Apr 24, 2019
NCT02626013Lead Sponsor
Real-world Evidence Prospective Study on the Effect of Nab-paclitaxel Treatment on the Clinical Outcomes and HRQoL in Patients With MBC in Greece
N/ACompleted
156 participants
Started: Apr 12, 2016 · Completed: Sep 12, 2018
NCT02608515Lead Sponsor
A Retrospective Chart Review Study of the Outcomes of 2nd Line Therapy With LEn/Dex in Greek Patients With R/R Multiple MyEloma and the Treatment PatterNs Following Progressive Disease
N/ACompleted
207 participants
Started: Dec 31, 2015 · Completed: Sep 30, 2016
View all 7 trials →